Skip to Content
Merck
  • Activity of 7-methyljuglone derivatives against Mycobacterium tuberculosis and as subversive substrates for mycothiol disulfide reductase.

Activity of 7-methyljuglone derivatives against Mycobacterium tuberculosis and as subversive substrates for mycothiol disulfide reductase.

Bioorganic & medicinal chemistry (2007-09-25)
Anita Mahapatra, Sannah P N Mativandlela, B Binneman, P B Fourie, Chris J Hamilton, J J M Meyer, F van der Kooy, Peter Houghton, Namrita Lall
ABSTRACT

The naphthoquinone 7-methyljuglone (5-hydroxy-7-methyl-1,4-naphthoquinone) has previously been isolated and identified as an active component of root extracts of Euclea natalensis which displays antitubercular activity. Herein, a series of synthetic and plant-derived naphthoquinone derivates of the 7-methyljuglone scaffold have been prepared and evaluated for antibacterial activity against Mycobacterium tuberculosis. Several of these compounds have been shown to operate as subversive substrates with mycothiol disulfide reductase. The absence of a direct correlation between antitubercular activity and subversive substrate efficiency with mycothiol disulfide reductase, might be a consequence of their non-specific reactivity with multiple biological targets (e.g. other disulfide reductases).

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
1,4-Naphthoquinone, purum, ≥96.5% (HPLC)
Supelco
Isoniazid, analytical standard, ≥99% (TLC)
Sigma-Aldrich
Menadione, crystalline
Sigma-Aldrich
Menadione, meets USP testing specifications
Supelco
Menadione (K3), analytical standard
Sigma-Aldrich
1,4-Naphthoquinone, 97%
Sigma-Aldrich
4-Fluoro-3-methylphenol, 98%